To a trained eye, the chromosome chart (karyotype) above has 4 irregularities, circled in red. Theyre chromosome pairs of uneven size.
The chromosomes represent genetic material missing or extra, but also a beautiful girl. Her father contacted me after he read my recent post about a friends child with a rare mutation in a single gene, a more typical driver of so-called diagnostic odysseys. Did I have any insight on treatments for his daughter? Hed send her lab reports.
The notations were in Hebrew, but the universal language of chromosome charts spoke clearly to me. The chromosome pairs are size-ordered, its members matching, but pairs 9, 14, 15, and 16 look like tall and short dance partners. This was something more profound than a single gene glitch, or even a missing or extra chromosome.
Shattered and Scattered
Aviya has an exceedingly rare condition called chromothripsis, which is Greek for shattered colored bodies. Breaks that sever both strands of the DNA double helix riddle one or more chromosomes. Lost pieces may have been ejected and glommed onto other chromosomes at or before fertilization, creating the karyotype that veers from the neat, normal, 23-pair organization.
Chromothripsis is best studied in cancer cells, where the genome is shot to smithereens, but only a few dozen people in the world are known to have it in all their cells. When the medical team at Schneider Childrens Medical Center in Israel discovered the childs condition, they told the parents that only 30 cases had been reported in the medical literature. Ever.
For some of the cases, researchers deduced how chromosomes broke long ago, in developing eggs. Since human eggs sit in an ovary for dozens of years before they mature at the moment of fertilization, enough time elapsed for natural DNA repair to fix some of the breaks and fill in small deletions.
In the few cases of fetuses surviving chromothripsis, enough of the genome must have been knit back together, even if in the wrong places, to sustain development and life. Sperm mature much too quickly, over a few months, to heal themselves in this way.
So a person with chromothripsis is about as rare as rare can be. Each case is unique, for the genomes of no two people that come apart in this highly unusual manner are stitched back together in exactly the same way.
The Diagnostic Odyssey
Aviya is now just past her second birthday and is beginning to walk, although she doesnt yet talk. Her symptoms unfolded early and rapidly, about 3 months after her birth in May 2017.
She started throwing up multiple times a day and regardless of how much or what she ate, breast milk or formula, she would not gain weight. She wasnt reaching developmental milestones. The physical therapist noted her hypotonia (low muscle tone, or floppiness), her dad recalled. Her weight steadily dropped, as the vomiting worsened.
Hospital stays followed. Tests and scans ruled out intestinal malrotation, while neurological tests and abdominal ultrasounds were normal too. Doctors inserted a nasogastric tube, for nutrition.
At 7 months old, Aviya started at the failure-to-thrive clinic at Schneiders, where she had tests and evaluations for physical therapy (PT) and occupational therapy (OT). She also met with an eating specialist.
Everyone poked and prodded and measured and checked. She had blood tests, gave stool samples, had CT scans, MRI images, and drank stuff for x-rays through the GI tract, Yosef said. The doctors initially suspected malrotation of the intestines behind the vomiting, but that didnt hold up. They didnt find any evidence or suspicion of anything amiss based on symptoms only, he added. Heart, brain, blood, all looked ok.
The next step: probing genetics. A chromosomal microarray test (CMA; for small deletions and insertions) and a karyotype revealed the four unusual chromosomes, deemed a complex chromosomal rearrangement. Tests for selected single-gene conditions, like Beckwith-Wiedemann syndrome, were negative.
Further analysis led to the chromothripsis explanation. Because the parents CMA tests and karyotypes were normal, their daughter hadnt inherited her unusual chromosomes they originated in her, likely an ultra rare event in a lone developing egg, followed by spectacular natural healing.
But deducing chromosomal origins and even contemplating whether a gene therapy might be possible for a situation so complex took a backseat to addressing Aviyas daily challenges. First, she had to be able to eat.
Focusing on Symptoms
Vomiting send Aviya to the hospital regularly. For 9 months she received supplemental feedings through a nasogastric tube, and the frequency of episodes slowed as she slowly gained weight. When the gaining once again slowed, and days-long bouts of vomiting led to more hospitalizations, doctors performed a procedure called PEG (for percutaneous endoscopic gastrostomy). A tube through the abdominal wall into her stomach now delivered nutrients. That was done on March 5th, 2019.
The vomiting finally ceased and Aviya has reached the 10th percentile in body weight, up from inexorably losing. Shes also catching up on gross motor skills and reaching developmental milestones. And shes intelligent. She understands basically everything you tell her, for the level of a 2-year-old, Yosef said. Thats pretty amazing considering the number of unusual chromosomes and how many genes affect brain function.
But boosting nutrition isnt the only intervention helping Aviya to overcome whatever limits her chromosomes have set. Yosef credits her overall improvement to the excellent care shes been receiving at a special education day care program near their home on the West Bank. Shes been attending since November, and she gets PT, OT, speech therapy, and does specialized exercises tailored to her abilities. Aviya also returns to the failure-to-thrive clinic every other month, down from once a week.
Instead of Fixing Genes, Address Symptoms
When parents become sucked down the rabbit hole of rare diseases, they quickly learn about biotech approaches: enzyme therapies, stem cells, antisense oligonucleotides, gene therapy, and even gene editing. Its overwhelming. Some of the parents DNA Science has featured rapidly became nearly as expert as some of the scientists developing new treatments (see Celebrating the Moms of Gene Therapy).
Would exome sequencing shed any more light on the situation, or it would just lead to more questions that no one has the answers to? Yosef asked me. Exome sequencing, which reveals the information in the part of the genome that encodes protein, might actually provide too much information, noting too many missing genes to consider treatments for all of them. But it might reveal which proteins Aviya cant make, and maybe that could lead to something.
The TMI issue also affects the utility of a gene therapy for chromothripsis: too many targets.
Specific mutations in single genes cause the conditions for which gene therapy has been FDA approved Luxturnato treat a form of inherited blindnessand Zolgensmato treat spinal muscular atrophy (SMA). The cost of gene therapy for now is prohibitive, although the manufacturers help with patient access. Zolgensma recently made headlines for its $2.1 million price tagand Luxturna for both eyes is about $850,000. The gene therapies, though, are intended to be one-and-done, or at least just in need of a booster. And the alternatives, in these two frontrunners, are blindness or death.
Given the cost of gene therapy and its restriction to genetic disruptions far simpler than the chaos of Aviyas chromosomes, its great that standard therapies are having an effect.
Shes been improving by leaps and bounds in everything, from how much she eats to what shes willing to try to her understanding of everything. Shes just so much better, since the PEG and beginning the special ed day care. She eats more, theres more variety to her food choices, and shes willing to try anything, Yosef said.
He knows that no research team or company is going to pursue a treatment for a sample size of one. What were doing is the best we can do. Its working, so if it aint broke dont fix it. If we find something else to do, then for sure well do it, but in the meantime, were doing the best that we figured out for now. Well see what the future holds.
So Ill end with a shout-out to the supportive therapies that help so many. Even after a sophisticated gene therapy that takes years, if not decades, to take to a clinical trial, supportive therapies are critical to maximizing any effect, on a daily basis. Perhaps no one knows that better than Lori Sames, whose daughter Hannah had gene therapy for giant axonal neuropathy in 2016. (See After Gene Therapy: Hannahs Journey Continues).
PT is incredibly important! When Hannah was a toddler and developed low muscle tone, our first sign something was wrong prior to her diagnosis, her first physical therapist emphasized how important it was to let her do everything. Do not pick her up and put her in her car seat. Open the door of the minivan and let her crawl in and hoist herself up into the car seat. Let her walk. If shes tired and asks to be carried for a bit, carry her for a bit. Keep her as active as you can for as long as you can.
Hannahs PT continues today. While standing, she does squats, leaning back as if shes sitting but powering back through to a stand before she touches the seat. Were trying to keep her hips and quads and hamstrings strong. We have her stand twice an hour and shes in the EasyStand device at least an hour a day. This is critically important for her internal organs and bone density, Lori recently told me.
Aviya is a wonderful, spirited child.
Shes a fun-loving, constantly happy kid, even though she has spent more time in the hospital then most people I know. Even while she was hospitalized she would always smile at the doctors and nurses and play with the other kids, with as much energy as she had. She loves taking things out of and putting them into bags or boxes. She loves hugging dolls and pretending to feed them. She loves playing outside with plants and watching ants going back and forth. She loves to be part of everything and to crawl around the house, and loves when people talk or sing to her and she talks and sings back, said her father.
See the original post:
- The Wet AMD Gene Therapy Race - Adverum Biotechnologies Vs. Regenxbio - Seeking Alpha - June 5th, 2020
- Cell and gene therapies - Lexology - May 28th, 2020
- Bicoastal startup Kriya Therapeutics to grow gene therapy manufacturing in NC - WRAL Tech Wire - May 28th, 2020
- Expression Therapeutics Announces IND Approval by the FDA for Hemophilia A Gene Therapy | DNA RNA and Cells | News Channels - PipelineReview.com - May 28th, 2020
- Troubleshooting the Development of New Gene Therapies - Technology Networks - May 28th, 2020
- Lab Mice Shed Fat and Build Muscle with Gene Therapy - The Great Courses Daily News - May 28th, 2020
- Reversing SHANK3 mutations in mice mitigates autism-like traits - Spectrum - May 28th, 2020
- Orchard Therapeutics to Present at Virtual Investor Conferences in June - Yahoo Finance UK - May 28th, 2020
- Gene Therapy market worldwide is projected to grow by US$3.3 Billion - GlobeNewswire - May 28th, 2020
- Generation Bio tees up $125M IPO to push next-gen gene therapies - FierceBiotech - May 27th, 2020
- Expression Therapeutics Announces IND Approval by the FDA for Hemophilia A Gene Therapy - PRNewswire - May 27th, 2020
- Novartis' gene therapy approved in Europe, talks ongoing on price - BioPharma-Reporter.com - May 27th, 2020
- NOVASEP and LYSOGENE Announce their New Collaboration for Development and Production of GM1 Gangliosidosis Gene Therapy Product - Business Wire - May 27th, 2020
- Evox Therapeutics Appoints Martin Andrews as Non-Executive Director - BioSpace - May 27th, 2020
- New Zolgensma 'inflection point' is here as Novartis snags EU nod for SMA gene therapy - FiercePharma - May 27th, 2020
- Gene therapy could help millions of ash trees fight deadly beetle Emerald Ash Borer - inews - May 27th, 2020
- Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq - Xconomy - May 27th, 2020
- European regulators accept FibroGen's anemia drug for review; Passage Bio's lead gene therapy gets more love from the FDA - Endpoints News - May 27th, 2020
- QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development - PRNewswire - May 19th, 2020
- Novartis wins conditional EU approval for gene therapy Zolgensma - Reuters - May 19th, 2020
- The Roller Coaster of Gene Therapy... - Labiotech.eu - May 19th, 2020
- Gene therapy reduces fat and builds muscle in mice - BioNews - May 19th, 2020
- Forget ExerciseThese Mice Got Ripped With Gene Therapy - Singularity Hub - May 19th, 2020
- UPDATED: Pfizer gene therapy ups levels of dystrophin expression in Duchenne trial but another safety setback mars results - Endpoints News - May 19th, 2020
- Thermo Fisher to invest $180M in new gene therapy plant - BioPharma Dive - May 19th, 2020
- Beam Therapeutics Taking Novel Approach to Gene Therapy - Yahoo Finance - May 19th, 2020
- Gene-Therapy Treatments for Tay-Sachs, Sickle Cell to Be Featured in Online Gathering - Barron's - May 19th, 2020
- Sarepta And Dyno Therapeutics Will Develop Next-Gen Gene Therapy Vectors - Contract Pharma - May 19th, 2020
- New gene therapy cuts fat and builds muscle with ease. But theres a catch - Digital Trends - May 19th, 2020
- New Gene Therapy Promises You Will Get Ripped Without Stepping in a Gym - Interesting Engineering - May 19th, 2020
- Merck KGaA adds to gene therapy manufacturing boom with 100M facility in California - Endpoints News - May 19th, 2020
- Japan's health insurance to cover 167 million gene therapy drug - The Japan Times - May 19th, 2020
- COVID 19 PANDEMIC: Gene Therapy Market Is Set To Experience Revolutionary Growth By 2025 - Cole of Duty - May 19th, 2020
- Magenta Therapeutics Presents Data at Annual Meeting of American Society of Gene and Cell Therapy Demonstrating Cells Mobilized with MGTA-145 in a... - May 19th, 2020
- Passage Bio Announces Expansion of Gene Therapy Collaboration with University of Pennsylvania - GlobeNewswire - May 11th, 2020
- Orgenesis sees 1Q revenue rocket driven by its Cell and Gene Therapy Biotech platform - Proactive Investors USA & Canada - May 11th, 2020
- Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat dietinduced obesity - Science Advances - May 11th, 2020
- BioMarin broadens its gene therapy horizons with a new R&D alliance in rare cardio cases - Endpoints News - May 11th, 2020
- BioLife Solutions to Report First Quarter 2020 Financial Results and Provide Business Update on May 14th, 2020 - Chinook Observer - May 11th, 2020
- Adverum soars on early gene therapy data; BerGenBio raises 45.4M on the heels of Covid-19 move - Endpoints News - May 11th, 2020
- Neurophth Therapeutics Announces Presentations at ASGCT and ARVO Annual Meetings - PRNewswire - May 11th, 2020
- Genprex Enters Into Exclusive Worldwide Patent and Technology License Agreement for Combination of its TUSC2 Gene Therapy with Immunotherapies -... - May 11th, 2020
- Study suggests effective fat-reducing therapy - Tech Explorist - May 11th, 2020
- Senti Biosciences to Present on Gene Circuit-Based Therapies at the 2020 ASGCT Annual Meeting - Business Wire - May 11th, 2020
- Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma GmbH Enter into Strategic Clinical and Commercial Manufacturing Agreements with... - May 11th, 2020
- Flexion Therapeutics Announces Virtual Poster Presentations for FX201, an Intra-Articular Gene Therapy Candidate for the Treatment of Osteoarthritis,... - May 11th, 2020
- UPDATE Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting - GlobeNewswire - May 11th, 2020
- This Gene Is a Molecular "Knob" That Fine-tunes Our Cortex's Electrical Activity - Technology Networks - May 11th, 2020
- Gene Therapy for Rare Disease Market 2020 Coronavirus (Covid-19) Business Impact 2026 Growth Trends by Manufacturers, Regions, Type and Application,... - May 11th, 2020
- Can gene therapy help develop coronavirus vaccine? Researchers banking on this technology for breakthrough - MEAWW - May 11th, 2020
- A Tribute to Max Randell, Gene Therapy Pioneer - PLoS Blogs - April 27th, 2020
- Merck KGaA to spend $110M on new gene therapy facility in California - BioPharma Dive - April 27th, 2020
- Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies |... - April 27th, 2020
- Glaucoma can be successfully treated with gene therapy - Telangana Today - April 27th, 2020
- Regenxbio Is A Leader In Gene Therapies - A Case Where The Platform Is Worth More Than The Pipeline - Seeking Alpha - April 27th, 2020
- UK Startup to Manufacture Cell and Gene Therapies with... - Labiotech.eu - April 27th, 2020
- Sangamo- Early-Stage Progress in Gene Therapy - Yahoo Finance - April 27th, 2020
- Inclusive Comprehension 2020: Gene Therapy Market (Trending PDF) Addressing Structure, Scope, Potential, and Growth Prospects Till 2029 - Jewish Life... - April 27th, 2020
- Ziopharm Oncology to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on May 7, 2020 - Yahoo Finance - April 27th, 2020
- Lysogene S.A. (EPA:LYS): When Will It Breakeven? - Simply Wall St - April 27th, 2020
- Diabetes reversed in mice with genetically edited stem cells derived from patients - Washington University School of Medicine in St. Louis - April 27th, 2020
- Addressing the potential impact of coronavirus disease (COVID-19) on Hemophilia Gene Therapy Market: Quantitative Analysis from 2019 to 2025 to Enable... - April 27th, 2020
- COVID-19 impact: Gene Therapy Market 2019 Business Insights,Top Companies,Growth, Market Size Global Market Share, Trends, Outlook, Opportunity and... - April 27th, 2020
- Gene Therapy For Inherited Genetic Disorders Market Overview, Top Companies, Region, Application and Global Forecast by 2026 - Latest Herald - April 27th, 2020
- Glaucoma Could Be Successfully Treated With Gene Therapy - Technology Networks - April 26th, 2020
- Reversing diabetes with CRISPR and patient-derived stem cells - FierceBiotech - April 26th, 2020
- Glaucoma can be successfully treated with gene therapy - International Business Times, Singapore Edition - April 26th, 2020
- AskBio acquires BrainVectis to expand its gene therapy portfolio - News.MarketSizeForecasters.com - April 26th, 2020
- 'We're really at a tipping point': COVID-19 brings research into other medical conditions to a grinding halt - CBC.ca - April 26th, 2020
- ThermoGenesis and ImmuneCyte Joint Venture Developing Several Convalescent Plasma and Antibody Therapeutic Approaches Against COVID-19, Featured on... - April 26th, 2020
- Gene Therapy Market : Global Outlook and Forecast 2020-2025 - Surfacing Magazine - April 26th, 2020
- Gene Therapy for Frontotemporal Dementia With a GRN Mutation Gets Fast Track Status - Monthly Prescribing Reference - March 26th, 2020
- Redpin bags A round to advance Chantix-controlled gene therapies - FierceBiotech - March 26th, 2020
- Vycellix and Avectas Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies - BioSpace - March 26th, 2020
- Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies - BioSpace - March 26th, 2020
- Global Viral Vector and Plasmid DNA Manufacturing Market to Surpass US$ 2,205.6 Million by 2027 - CMI - Yahoo Finance - March 26th, 2020
- Codexis and Takeda partner on gene therapies for rare diseases - Pharmaceutical Technology - March 26th, 2020
- Genprex Strengthens Leadership Team with the Appointment of Two Accomplished Life Science Executives - Yahoo Finance - March 26th, 2020
- Study reveals gene therapy may help in treating cardiac disease - The Siasat Daily - March 26th, 2020
- TCR therapy an attractive alternative to CAR T for immunotherapy - Drug Target Review - March 26th, 2020